Bullish
INmune Bio (NASDAQ: INMB) wins FDA Fast Track status for XPro in early Alzheimer’s disease
INmune Bio Inc. (NASDAQ: INMB) has been granted FDA Fast Track designation for its drug XPro™ (pegipanermin), a selective soluble TNF inhibitor, for t...